Optimizing micafungin dosing in children

Pediatric Infectious Disease Journal

Volumn 31, Issue 11, 2012, Pages 1211-1212

  Zhao, Wei ^a   Hope, William W ^b   Manzoni, Paolo ^c   Jacqz Aigrain, Evelyne ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c S ANNA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; MICAFUNGIN;

CANDIDEMIA; CANDIDIASIS; DRUG EFFICACY; HUMAN; LETTER; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDEMIA; CANDIDIASIS, INVASIVE; ECHINOCANDINS; FEMALE; HUMANS; LIPOPEPTIDES; MALE;

EID: 84867755546     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182624bac     Document Type: Letter

References (7)

1. Undre NA, Stevenson P, Freire A, et al. Pharmacokinetics of micafungin in pediatric patients with invasive candidiasis and candidemia. Pediatr Infect Dis J. 2012;31:630-632.
2. Kuse ER, Chetchotisakd P, da Cunha CA, et al.; Micafungin Invasive Candidiasis Working Group. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet. 2007;369: 1519-1527. (Pubitemid 46670281)
3. Food and Drug Administration. FDA guidance for industry: exposure-response relationships-study design, data analysis, and regulatory applications. Available at: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm072109.pdf. Accessed April 02, 2012.
4. Hiemenz J, Cagnoni P, Simpson D, et al. Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant. Antimicrob Agents Chemother. 2005;49: 1331-1336. (Pubitemid 40463357)
5. Hope WW, Smith PB, Arrieta A, et al. Population pharmacokinetics of micafungin in neonates and young infants. Antimicrob Agents Chemother. 2010;54:2633-2637.
6. Hope WW, Mickiene D, Petraitis V, et al. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. J Infect Dis. 2008;197:163-171. (Pubitemid 351263481)
7. Manzoni P, Benjamin DK, Hope W, et al. The management of Candida infections in preterm neonates and the role of micafungin. J Matern Fetal Neonatal Med. 2011;24(suppl 2): 24-27.